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Abstract
Purpose. Conservative treatment in the form of limited surgery and post-operative radiotherapy is controversial in hand and
foot sarcomas, both due to poor radiation tolerance of the palm and sole, and due to technical difficulties in achieving
adequate margins.This paper describes the local control and survival of 41 patients with soft tissue sarcoma of the hand or
foot treated with conservative surgery and radiotherapy.The acute and late toxicity of megavoltage radiotherapy to the hand
and foot are described. The technical issues and details of treatment delivery are discussed. The factors in¯ uencing local
control after radiotherapy are analysed.
Subjects. Eighteen patients had sarcomas of the hand and 23 of the foot. All patients received post-operative radiotherapy,
the majority receiving a dose of 60 Gy in 2-Gy daily fractions using a two-phase treatment.
Results. The acute and late toxicity of treatment were within acceptable limits.The actuarial 5-year overall survival of the
whole patient group was 67.6% and the local relapse-free survival was 44%.The local control was similar in tumours of hand
and foot, and in patients treated at ® rst presentation or relapse.
Discussion. Post-operative radiotherapy to the hand or foot appears to be a well tolerated treatment resulting in long-term
local control in a signi® cant proportion of patients. The increased frequency of recurrence within the high-dose volume
suggests the need for the use of higher total doses of radiotherapy.
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Introduction
Conservative surgery combined with radiotherapy is
the recommended treatment for soft tissue sarcoma
of the extremity.
1± 3 However, this approach is
controversial in sarcoma of the hand or foot, due to
difficulty in achieving wide excision margins and poor
radiation tolerance of normal tissues. Resection alone
results in a high local recurrence rate of 40± 50%;
thus amputation is usually recommended as the treat-
ment of choice.
4± 6 However, several recent reviews
suggest that combined modality treatment with
limited surgery plus radiotherapy can result in good
local control with preservation of function.
7± 13 Due
to the rarity of soft tissue sarcoma in the distal
extremities, most reviews include only a small number
of patients, treated with a variety of radiation
techniques. In addition most series include sarcomas
of the wrist and ankle.The additional problem with
the hand or foot is the low radiation tolerance of
the skin of the palm and sole compared to the rest
of the limb, and the limitation of salvage surgery
for recurrence.
In this paper we retrospectively review 41 patients
with soft tissue sarcoma arising from hands or feet
treated with conservative surgery and post-operative
radiotherapy. The acute and late toxicity of mega-
voltage radiotherapy, local control and functional
outcome, as well as feasibility of salvage therapy, are
analysed.
Subjects and methods
Patient characteristics
Between 1981 and 1997, 41 patients with soft tissue
sarcoma arising from the hand or foot received
radiotherapy at the Royal Marsden Hospital. All
patients had non-metastatic disease and treatment
was intended to be curative. The mean age was 39
years (range 13± 76 years). Twenty-one patients were
male and 20 female. Eighteen had tumours of the
hand and 23 of the foot.Thirty-one patients were irradi-
ated following surgery at initial presentation and 10
after surgery for local recurrence. Full history and
clinicalexamination were performed.The surgical notes
and pathology reports were reviewed. Investigations
included chest X-ray and tomographic scans of the
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of sarcoma was con® rmed in all patients. The patient
and tumour characteristics are summarised in Table 1.
Treatment details
All patients underwent initial surgery, ranging from
biopsy to wide local excision, depending on the loca-
tion and size of tumour. Four patients underwent
biopsy only. Fourteen underwent intracapsular exci-
sion (i.e. excision with macroscopic residual tumour),
12 marginal excision (i.e. excision of gross tumour
with pseudo capsule) and 11 wide excision (excision
of tumour with a margin of normal tissue, including
3 requiring ray amputation of a digit). Six patients
underwent skin grafting as part of the initial surgical
procedure. The patients who underwent suboptimal
surgery were operated on in other hospitals including
centres abroad, and were referred post-operatively
for radiotherapy. The margins of excision were
assessed from the histopathology report. Nineteen
patients had clear excision margins and 3 had close
margins. The excision margins were microscopically
positive in 13 patients and 6 had gross residual tumour
prior to radiotherapy.
All received post-operative radiotherapy. Twenty-six
received conventional dose fractionation, ranging from
50 Gy in 25 fractions over 5 weeks to 60 Gy in 30
fractions over 6 weeks. Six patients received hyper-
fractionated radiotherapy to a dose of 72 Gy in 60
fractions of 1.2 Gy over 6 weeks, treating twice daily.
Nine patients treated in the earlier part of the study
were hypofractionated to a dose of 39.6 Gy in six
fractions each of 6.6 Gy, given once a week.
The technique of radiotherapy was determined by
the site and extent of tumour. Twenty-six patients
were treated using a large phase I volume to a dose of
50 Gy in 25 fractions in the conventional group or
60 Gy in 50 fractions in the hyperfractionated group.
This was followed by a smaller phase II volume adding
10 Gy in ® ve fractions or 12 Gy in 10 fractions
respectively during the sixth week. Fifteen patients
received a single phase treatment throughout. All
patients were treated with the limb immobilised in a
cast (Figs 1 and 2).
Treatment portals were selected according to
pre-operative computerised tomography (CT) scans
and surgical notes. Irradiation of the entire circumfer-
ence of the limb was avoided, with care being taken
to spare a corridor of skin and subcutaneous tissue.
The wrist and ankle joints were excluded from the
high dose volume whenever possible. In patients with
involvement of the foot, the sole was spared whenever
possible. A direct electron beam of energy ranging
from 5 to 10 MeV was used in 7 patients; photon
beams of 5± 6 MeV or Cobalt-60 were used in the
remaining 34. Photon therapy techniques included
parallel opposed or oblique wedged beams. The
surgical scar required bolus to build up the skin dose
in only 3 patients.
The overall treatment time ranged from 28 to 55
days (median 42 days). Two patients required treat-
ment interruption due to an acute skin reaction. Six
patients received chemotherapy as part of their initial
therapy. The 3 patients with Ewing’s sarcoma and
three with rhabdomyo-sarcoma received regimes
containing vincristine, actinomycin D, adriamycin and
ifosfamide along with local radiotherapy. One patient
with angiosarcoma had been treated with pre-
radiotherapy intra-arterial adriamycin.
Follow up evaluation
Patients were followed up every 2 months for the first
year and at longer intervals thereafter. Clinical
examination and chest X-ray were performed at each
visit. Further investigations were performed only when
clinically indicated.
Functional status and treatment toxicity
The pre-radiotherapy functional status was retro-
spectively graded as normal, mild dysfunction or
severe dysfunction (Table 2). Acute and late morbidity
of radiotherapy were scored using the RTOG criteria.
Limb oedema was scored using the NCIC late limb
oedema scale. Function was also assessed at the time
of last follow-up using the functional scales.
Table 1. Patient characteristics
Factor
Number of
patients Percentage
Age at diagnosis (years)
12± 30 11 26.8
>30± 50 20 48.8
>50 10 24.4
Status at presentation
Primary 31 75.6
Recurrent 10 24.4
Gender
Male 21 51.2
Female 20 48.8
Site
Hand: Dorsum 4 9.8
Palm 4 9.8
Fingers 10 24.4
Foot: Dorsum 12 29.3
Sole 7 17.1
Medial aspect 3 7.3
Toes 1 2.4
Histology
Synovial sarcoma 12 29.3
Clear cell sarcoma 7 17.1
Epitheloid sarcoma 6 14.6
Rhabdomyosarcoma 3 7.3
Liposarcoma 2 4.9
Angiosarcoma 2 4.9
Others 9 21.9
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Survival analysis was performed using the Kaplan±
Meier method and log-rank test. Analysis was done
separately for overall survival and local recurrence.
Survival was calculated from the date of surgery in all
patients.
Results
The median follow up was 65 months (range 3.5± 205
months). Twenty-one patients had a completely
normal pre-radiotherapy functional status; 13 had
mild dysfunction and 7 severe dysfunction.All patients
completed the planned course of radiotherapy,
although 2 required treatment interruption due to
acute toxicity. Thirty-nine patients had acute skin
morbidity following radiotherapy with 14 patients
having grade 1 reactions, 20 grade 2, and 5 grade 3
reactions. Two of the 6 patients with skin grafts
developed ulceration of the graft which was managed
conservatively, and healed without further surgical
intervention.
Fig. 1. A 65-year-old man with a myxoid liposarcoma who presented with a large mass on the dorsum of the foot for which amputa-
tion was recommended.Tumour arose on the plantar aspect and was eroding two metatarsals.
Fig. 2. Left lateral ® eld in perspex immobilisation cast of patient illustrated in Fig. 1. encompassing almost entire foot and ¯ exor and
extensor muscles up to the patella.This was opposed with a medial ® eld to deliver a dose of 50 Gy to the 100% isodose in 25 fractions
over 5 weeks, to resolve inhomogeneity.There is sparing of the terminal phalanges, sole of foot, Achilles tendon and a posterior corridor
of normal tissue. A similar ® eld arrangement was used for phase 2, but with ® elds con® ned to the foot.
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assessed in 34 patients treated prior to 1995, who
had follow-up in excess of 30 months.The late toxicity
of treatment is summarised in Table 3. No patient
had persistent pain requiring analgesia.
Of these 34 patients, 14 (41%) developed local
recurrence, of whom 9 had local recurrence alone
and 5 had distant metastases in addition. Seven
patients recurred within the phase II (radical dose)
volume of whom 6 had either gross or microscopic
disease. Five patients recurred in the phase I volume,
and 2 patients had a marginal recurrence. Salvage
treatment for local recurrence comprised wide
re-excision in 8, ray amputation of digits in 3 and
below knee amputation in 2, and 1 patient with
inoperable recurrence underwent palliative re-
irradiation. Four of 8 patients developed further local
recurrence after wide re-excision. Of these, 3 had a
further re-excision but 1 required a below elbow
amputation. Four patients developed regional lymph
node metastases of whom 2 had local recurrence in
addition. Twelve patients developed distant metas-
tases, of whom 6 had distant metastases alone, 5
distant and local relapse, and 1 distant and nodal
relapse.
The median time to local recurrence was 19 months
(range 4.5± 85 months) and to distant metastases was
18 months (range 5± 84 months). The pattern of
failure in various potential prognostic groups is
summarised in Table 4. High grade tumours had
higher rates of both local and nodal failure (42 and
13% respectively). The margins of surgical excision
did not appear to in¯ uence local control or metastatic
rate, although these were assessed retrospectively from
the pathological report in most cases. Histology of
the primary tumour did not in¯ uence local control
overall, although the subset of patients with Ewing’s
sarcoma or rhabdomyosarcoma had low rates of local
recurrence (1/6 patients). Relapse rates were higher
for patients treated for recurrence as compared to
treatment at initial presentation.
Kaplan± Meier estimates showed an actuarial 5-year
overall survival of 67.6% for the whole group
(Fig. 3). Patients with hand sarcomas had overall
survival of 73.3% compared to 63.6% for foot
sarcomas (95% con® dence interval, CI, 0.4± 4.8)
(Fig. 4).
Twenty-eight patients were free of disease at the
time of last follow-up. Six patients were alive with
disease (4 with distant metastases, 1 local and 1 nodal
disease). Seven patients died of distant metastases.
No patient died of uncontrolled local tumour.
The post-radiotherapy functional status was assessed
at the time of last follow-up. No assessment could be
made in the 2 patients who underwent extensive surgery
for local recurrence. Of the remainder, 15 had normal
function,14 mild dysfunction and 3 had major dysfunc-
tion.The late cosmetic and functional outcome is shown
in Figs 5 and 6.
Discussion
Although large series have reported the results of
conservative surgery and radiotherapy for extremity
sarcomas, patients with involvement of the hand or
foot are few in number.
1,14 A high incidence of late
morbidity and functional de® cits, often necessitating
amputation, has been reported following irradia-
tion.
15,16 In view of the low radiation tolerance of the
skin of the palm and sole, radical resection, (often
amputation), has been recommended as the primary
treatment.
4,17 However, limb conservation therapy
has gradually gained acceptance in this patient group.
An improvement in radiation techniques and recogni-
tion of the importance of excluding the entire joint
from the high-dose volume, plus sparing of a corridor
of normal tissues, have resulted in reduced late
morbidity from radiotherapy. The routine use of CT
and magnetic resonance imaging (MRI) scans to
de® ne tumour volume more accurately and improved
immobilisation techniques have resulted in a reduced
high-dose planning target volume and ® eld sizes in
many patients. The use of three-dimensional plan-
ning and conformal radiotherapy may aid in further
reduction of acute and late normal tissue damage.
18
There are a few reports of good local control with
preservation of limb function using the combined
modality approach which are summarised in Table 5.
Table 2. Functional scale
Normal Completely normal function and
able to carry out all routine
activities. No oedema or pain.
Mild dysfunction Mild oedema of a limb, or some
decrease in range of movement of
a joint, or pain relieved by
non-narcotic analgesic.
Severe dysfunction Persistent moderate or severe
oedema, or severe ® brosis,
limitation of joint function, or pain
requiring narcotic analgesic.
Table 3. Late radiation morbidity (RTOG criteria and
NCIC late limb oedema scale)
Morbidity
Number of
patients Percentage
Skin: Grade I 12 35.3
Grade II 8 23.5
Grade II 2 5.9
Subcutaneous: Grade I 11 32.4
Grade II 2 5.9
Joints: Grade I 4 11.8
Grade II 5 14.7
Oedema: Grade I 9 26.5
Grade II 1 2.9
Bone: Grade I 3 8.8
20 R. Jyothirmayi et al.The usual recommended tumour dose for post-
operative radiotherapy of soft tissue sarcoma is
60 Gy.
7Twice daily fractionation has been proposed
to improve local control by permitting dose escala-
tion.
19In our series, 6 patients received hyperfraction-
ated radiotherapy to a total dose of 72 Gy over a
period of 6 weeks. Acute toxicity was well tolerated
although there was no apparent improvement in local
control or survival.
Most studies demonstrate a higher rate of local
failure in patients with positive surgical margins.
20,21
However, wide resection margins are difficult to
achieve in sarcoma of the hand or foot due to
anatomical constraints. The situation is analogous to
Table 4. Patterns of failure
Total number of Number of patients with (%)
Factor patients Local failure Nodal failure Distant failure
Site of tumour
Hand 12 5 (41.6) 3 (25.0) 2 (16.6)
Foot 22 9 (41.0) 1 (4.5) 10 (45.5)
Age (years)
<45 17 9 (53.0) 2 (10.5) 7 (36.0)
>45 17 5 (29.4) 2 (13.3) 5 (33.3)
Gender
Male 19 7 (36.8) 2 (10.5) 5 (26.3)
Female 15 7 (46.6) 2 (13.3) 7 (46.6)
Histology
Synovial sarcoma 11 7 (63.6) 0 (0) 5 (45.5)
Clear cell 4 1 (25.0) 3 (75.0) 0 (0)
Epitheloid 4 1 (25.0) 0 (0) 1 (25.0)
Tumour status
Primary 26 10 (38.4) 2 (7.7) 10 (38.4)
Recurrent 8 4 (50.0) 2 (25.0) 2 (25.0)
Grade
Low 3 1 (33.3) 0 (0) 1 (33.3)
High 31 13 (41.9) 4 (12.9) 11 (35.4)
Margins of excision
Negative 16 6 (37.5) 4 (25.0) 5 (31.3)
Close 3 2 (66.7) 0 (0) 3 (100)
Microscopic positive 10 4 (40.0) 0 (0) 2 (20.0)
Gross tumour 5 2 (40.0) 0 (0) 2 (40.0)
Radiotherapy
Conventional 20 8 (40.0) 4 (20.0) 6 (30.0)
Hyperfractionated 5 2 (40.0) 0 (0) 4 (80.0)
Hypofractionated 9 4 (44.0) 0 (0) 2 (22.2)
Fig. 3. Graph showing 5-year overall survival of patients with hand and foot sarcomas.
Radiotherapy for sarcoma of hand or foot 21sarcoma arising in the head and neck.
22 In our small
series, positive surgical margins were not associated
with signi® cant reduction in local control following
post-operative radiotherapy and a similar conclusion
has been reached by others.
10
In our series patients treated with post-operative
radiotherapy following surgery for locally recurrent
sarcoma had a higher rate of local failure compared
to those treated at initial presentation. This suggests
the need for routine post-operative radiotherapy at
the time of initial conservative surgery for hand and
foot sarcoma. The skin of both the palm and sole
tolerates radiation poorly. However, acute skin reac-
tions in our patient group were acceptable, with only
2 patients treated to large volumes requiring interrup-
tion of irradiation. Radiotherapy was well tolerated in
the 6 patients with skin grafts who suffered no late
complications. Grade 3 late skin toxicity in the form
of marked atrophy and telangiectasia developed in
only 5.9% of the whole series. Grade 3 late toxicity
was not observed in subcutaneous tissue, bone or
joints. These toxicity rates are comparable to those
previously reported in the literature. Post-radiotherapy
functional status was acceptable, with only 3 patients
having major dysfunction which was at least partly
due to surgery. No patient required amputation for
Fig. 4. Five-year overall survival in patients with sarcomas of the hands in comparison with that of patients with sarcomas of the feet.
Fig. 5. In order to preserve function, this young man underwent intracapsular excision of an epitheloid sarcoma from the heel. A dose
of 60 Gy in 2-Gy fractions was given with two lateral ® elds with sparing of the sole. Local recurrence developed in the sole 3 years later,
and was widely excised.A further dose of 60 Gy was delivered with a single electron beam. He remains free of disease 10 years later, is
able to ski, and is pain free.
22 R. Jyothirmayi et al.intractable late complication following radiotherapy.
There was no difference in the functional outcome
between patients with sarcoma arising in the hand
compared with those arising in the foot. However,
another series did report worse functional outcome in
foot sarcomas which might relate to weight bearing.
10
The local control rate in our series is low at 60%,
compared to previous reports (Table 5).This may be
due to the high proportion of high-grade tumours
(91%) in this patient group. In addition we had a
large proportion of patients treated for locally recur-
rent tumour (24%) compared to other series. Patients
treated with radiotherapy at local recurrence have
low local control rates compared to those treated
after the initial surgery.This suggests the need for the
routine use of post-operative radiotherapy in these
tumours after initial surgery.The majority of patients
in our series received a total dose of 60 Gy in 2-Gy
fractions, compared to higher total doses in other
series (median 65 Gy). The proportion of recur-
rences within the Phase II volume in patients with
positive margins suggests the need for dose escala-
tion in this patient group, possibly with conformally
shaped ® elds. Only 11 patients in this series underwent
a standard operation in the form of wide local exci-
sion prior to radiotherapy, and this may have
contributed to the poor local control.
The majority of local recurrences were salvaged
by further surgery. Only 6 patients required amputa-
tion for local recurrence, of whom 1 recurred on
four occasions. The use of post-operative
radiotherapy delayed amputation in this patient
group.
Distant metastasis remains the major cause of treat-
ment failure and death, especially in high-grade
sarcoma. In our series, all patients who died of disease
had evidence of uncontrollable distant metastases.
The use of a conservative approach avoided mutilating
surgery in these patients. The role of adjuvant
chemotherapy in hand and foot sarcoma requires
further evaluation but lack of effective agents is
common to sarcoma at all sites.
Fig. 6. This young lady is a casino pit boss requiring manual dexterity and attractive looking hands in order to continue in her
employment. She underwent local excision of a recurrent epitheloid sarcoma from the palm of her right hand. A dose of 60 Gy was
delivered using a single direct electron ® eld of 10 Mev energy, in 30 daily fractions, with wax build up. Moist desquamation demanded
an interruption of treatment, which was completed in a total of 53 days. She remains free of disease with normal function 13 years later.
Table 5. Results of conservative surgery and post-operative radiotherapy for hand and foot sarcoma
Number of patients
Author andYear Hand Foot Local control (%)
Okunieff et al. (1986)
8 17 0 14/17 (87.0)
Talbert et al. (1990)
10 39 39 57/78 (74)
Selch et al. (1990)
9 Ð 20 17/20 (85.0)
Colterjohn et al. (1997)
12 0 25 24/25 (96.0)
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Conservative surgery followed by radiotherapy
appears to be an effective treatment for soft tissue
sarcoma of the hand or foot. Post-operative radio-
therapy to a dose of 55± 60 Gy is well tolerated, with
a low incidence of moderate or severe late toxicity.
The anatomical location of sarcomas in the hand or
foot should not preclude the use of radiotherapy.
Radiotherapy results in long-term local control in a
signi® cant proportion of patients. Amputation may
be required for a small proportion of patients with
isolated multiple local recurrences following
radiotherapy.
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